News

PATH/Eric Becker
GHTC delivers statement on global strategy on health, innovation, and IP at WHO Executive Board Meeting
GHTC delivered a statement at the 146th session of the World Health Organization (WHO) Executive Board welcoming WHO efforts to address barriers to access to quality, affordable health products and urging the expansion of the essential diagnostics list as part of these efforts. The statement, issued through the Global Health Council, also encourages WHO and member states to support regulatory capacity strengthening and to better leverage the expertise of product development partnerships.
View

PATH/Matthew Dakin
GHTC issues statement on global vaccine action plan at WHO Executive Board Meeting
GHTC issued a statement at the 146th session of the World Health Organization (WHO) Executive Board applauding WHO and member states on achieving progress on global immunization targets and calling for greater investment in R&D for new vaccine technologies. The statement was issued through the Global Health Council in partnership with the Infectious Diseases Society of America.
View

PATH/Matthew Dakin
GHTC issues statement on ending tuberculosis at WHO Executive Board Meeting
GHTC issued a statement at the 146th session of the World Health Organization (WHO) Executive Board calling for member states to close the US$1.3 billion annual funding gap for tuberculosis R&D. The statement, issued through the Global Health Council in partnership with the Infectious Diseases Society of America, highlights the range of solutions urgently needed to stem the epidemic including new drugs, preventative therapies, vaccines, and diagnostics, including rapid molecular and point of care tools.
View

All News

Announcements

Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide